Delivery Order SPE2DB20D2014-SPE2DB24FA99H
- Not listed
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,902.80 award is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, serves as a prime contractor providing a wide range of pharmaceuticals and...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,087.08 award is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support U.S. military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a potential value of $3,739.40 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and medical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution services company. The $1,118.01 award is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5ml, a specialty pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $8,794.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty prescription medication. This award is part of Amerisourcebergen Drug Corp's larger prime contract with DLA, an indefinite delivery contract (IDC) valued at...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, with a potential value of $2,665.28 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and has been awarded numerous federal contracts by DLA to provide pharmaceuticals, medical supplies,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563452988 - TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The award has a potential value of $5,805.60 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of pharmaceuticals, medical supplies, and distribution services in support of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $14,505.14 order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $12,172.09 contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The $4,090.40 award is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The delivery order has a completion date of February 28, 2024 and was awarded on February 27, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp serves...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA99HDelivery Order
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,477.94 award is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical materials to DLA Troop Support Medical facilities supporting military treatment programs and medical facilities worldwide. No set-aside designation was used for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 2/5/24 |